Chondroitin with or without glucosamine vs placebo or control
Pain (short‐ and long‐term) Scale from 0 to 100 mm (lower is better) · patients with osteoarthritis
1 finding from 1 review
- no estimate extracted17 studies · 2262 participantsLow
Findings
What do systematic reviews say?
50 questions · 52 findings · 15 reviews · Musculoskeletal
No studies found 14 · 26.9%GRADE not reported 3 · 5.8%Very low 11 · 21.2%Low 18 · 34.6%Moderate 5 · 9.6%High 1 · 1.9%
Posterior cruciate ligament retention vs sacrifice (using the same arthroplasty design)
Re‐operation rate (not involving implant change, short and long term) · Patients receiving total knee arthroplasty with or without resection of the posterior cruciate ligament for the treatment of osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- Retention versus sacrifice of the posterior cruciate ligament in total knee arthroplasty for treating osteoarthritis 2013 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Posterior cruciate ligament retention vs posterior stabilised sacrifice
Re‐operation rate (not involving implant change, short and long term) · Patients receiving total knee arthroplasty with or without posterior stabilised design for the treatment of osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- Retention versus sacrifice of the posterior cruciate ligament in total knee arthroplasty for treating osteoarthritis 2013 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Posterior cruciate ligament retention vs sacrifice (all types of arthroplasty designs)
Re‐operation rate (not involving implant change, short and long term) · Patients receiving total knee arthroplasty with or without posterior stabilised design for the treatment of osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- Retention versus sacrifice of the posterior cruciate ligament in total knee arthroplasty for treating osteoarthritis 2013 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Oromucosal cannabis (Sativex) vs placebo
Pain at present McGill short form questionnaire ‐ Verbal rating scale (0‐5) · patients with pain management in rheumatoid arthritis
1 finding from 1 review
- no estimate extracted1 study · 58 participantsLow
Intervention not reported
Pain‐ short term VAS scale. Scale from: 0 to 10. ( · patients with lateral elbow pain
1 finding from 1 review
- no estimate extracted1 study · 24 participantsModerate
Intervention not reported
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with peripheral joint osteoarthritis
1 finding from 1 review
- no estimate extracted9 studies · 1835 participantsLow
Intervention not reported
Function (short term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with peripheral joint osteoarthritis
1 finding from 1 review
- no estimate extracted8 studies · 1767 participantsLow
Intervention not reported
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with knee osteoarthritis
1 finding from 1 review
- no estimate extracted8 studies · 1773 participantsLow
Intervention not reported
Function (short term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with knee osteoarthritis
1 finding from 1 review
- no estimate extracted8 studies · 1767 participantsLow